Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs Warfarin for LV Thrombus after STEMI
NCT03232398Phase 3Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Jan 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of apixaban in Left ventricular thrombosis (LVT) (2 arms), sponsored by Hadassah Medical Organization. Primary endpoint: Presence and dimensions of Left ventricular thrombus at 3 months. Started Jan 2018; status: completed.
02
Drugs
apixaban
03
Conditions
Left ventricular thrombosis (LVT)
Beyond the preview
Go deeper on NCT03232398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03232398.